GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
8Y4C | P0DTC2 | BA.2.86 S-trimer in complex with Nab XGv280 | |
8ZER | P0DTC2 | Crystal structure of the complex of Wuhan SARS-CoV-2 RBD (319-541) with P2C5 nanobody | |
8ZES | P0DTC2 | Crystal structure of the Wuhan SARS-CoV-2 RBD (333-541) complexed with P2C5 nanobody | |
9ATO | P0DTC2 | XBB.1.5 spike/Nanosota-3C complex | |
8YF2 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 prototype RBD in complex with raccoon dog ACE2 (local refinement) | |
8YFT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 alpha variant spike protein in complex with raccoon dog ACE2 (local refinement) | |
8XZ8 | P0DTC2 | BA.2.86 Spike in complex with bovine ACE2 (bound 1 ACE2) | |
8XZ9 | P0DTC2 | BA.2.86 Spike in complex with bovine ACE2 (bound 2 ACE2) | |
8XZA | P0DTC2 | BA.2.86 Spike in complex with bovine ACE2 (Local refinement) | |
8RJ7 | P0DTC2 | The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing nanobody 1.29 | |
8VIF | P0DTC2 | SARS-CoV-2 spike omicron (BA.1) ectodomain trimer in complex with SC27 Fab, local refinement | |
8VKE | P0DTC2 | SARS-CoV-2 spike omicron (BA.1) RBD ectodomain dimer-of-trimers in complex with SC27 Fabs | |
8VQ9 | P0DTC2 | Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | |
8VQA | P0DTC2 | Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | |
8VQB | P0DTC2 | Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | |
8UG9 | P0DTC2 | XBB.1.5 spike/Nb5 complex | |
8WXL | P0DTC2 | Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state) | |
8XUX | P0DTC2 | Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state) | |
8XUY | P0DTC2 | Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state) | |
8XUZ | P0DTC2 | Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state) | |
8XV0 | P0DTC2 | Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state) | |
8XV1 | P0DTC2 | Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state) | |
8XVM | P0DTC2 | Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state) | |
9IU1 | P0DTC2 | Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state) | |
8QZR | P0DTC2 | SARS-CoV-2 delta RBD complexed with BA.4/5-9 Fab | |
8C2R | P0DTC2 | SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody | |
8JVA | P0DTC2 | Cryo-EM structure of the N-terminal domain of Omicron BA.1 in complex with nanobody N235 and S2L20 Fab | |
8SWH | P0DTC2 | Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab | |
8X0X | P0DTC2 | Crystal structure of JE-5C in complex with SARS-CoV-2 RBD | |
8X0Y | P0DTC2 | Crystal structure of JM-1A in complex with SARS-CoV-2 RBD | |
8YZ6 | P0DTC2 | SARS-CoV-2 Spike (BA.1) in complex with Fab of JH-8B | |
9FGR | P0DTC2 | SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv76-77 (focused refinement) | |
8VAO | P0DTC2 | Simulation-driven design of prefusion stabilized SARS-CoV-2 spike S2 antigen | |
8HWS | P0DTC2 | The complex structure of Omicron BA.4 RBD with BD604, S309, and S304 | |
8S6M | P0DTC2 | SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments | |
8VIA | P0DTC2 | Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | |
8WMD | P0DTC2 | Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state) | |
8WMF | P0DTC2 | Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state) | |
8XI6 | P0DTC2 | SARS-CoV-2 Omicron BQ.1.1 Variant Spike Protein Complexed with MO11 Fab | |
9CO6 | P0DTC2 | BA.5 spike/Nanosota-9 complex | |
9CRC | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 3 closed RBDs | |
9CRD | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 1 open RBD | |
9CRE | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 3 closed RBDs | |
9CRF | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 1 open RBD | |
9CRG | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Gamma (P.1) variant 3 closed RBDs | |
9CRH | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Delta (B.1.617.2) variant 3 closed RBDs | |
9CRI | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Mu (B.1.621) variant 3 closed RBDs | |
9C44 | P0DTC2 | SARS-CoV-2 S + S2L20 | |
9C45 | P0DTC2 | SARS-CoV-2 S + S2L20 (local refinement of NTD and S2L20 Fab variable region) | |
9B82 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024